Clinical Trial: Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07699770) titled 'Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial' on April 15.

Brief Summary: This study is a multicenter, prospective, randomized, double-blind, placebo-controlled exploratory investigation conducted in China.

Study Start Date: June 15

Study Type: INTERVENTIONAL

Condition: Neuromyelitis Optica Spectrum Disorders (NMOSD) Neuropathic Pain

Intervention: DRUG: Crisugabalin

Crisugabalin 20-40mg bid

DRUG: Placebo+Crisugabalin

Placebo+Crisugabalin

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Tang-Du Hospital

Published by HT Digital Content Services with permission from...